V. Heinemann

Gemcitabine in the treatment of advanced pancreatic cancer: A comparative analysis of randomized trials

V. Heinemann · Seminars in Oncology · 2002 · 62 citations

Medicine, Oncology, Pharmacology +8

mFOLFOXIRI + panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild-type metastatic colorectal cancer m(CRC): A randomized phase II VOLFI trial of the AIO (AIO-KRK0109)

U.M. Martens, R. Knorrenschield, J. Greeve et al. · Annals of Oncology · 2017 · 24 citations · Full text

Medicine, Oncology, Pharmacology +10

mFOLFOXIRI + Panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild- type metastatic colorectal cancer m(CRC): a randomized phase II VOLFI trial of the AIO (AIO- KRK0109)

Tod M. Klingler, J. Riera-Knorrenschield, A. Tannapfel et al. · Annals of Oncology · 2018 · 21 citations · Full text

Medicine, Oncology, Pharmacology +14